Last reviewed · How we verify

NCT05059639

Exploring the Role of Almonds in Enhancing Immune Strength

Completed NA Last updated 31 January 2025
What this trial tests

NA trial testing Almond in Immune Health in 48 participants. Completed in 15 November 2024.

Timeline
15 November 2021
Primary endpoint
15 November 2023
15 November 2024

Quick facts

Lead sponsorSan Diego State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment48
Start date15 November 2021
Primary completion15 November 2023
Estimated completion15 November 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

San Diego State University

Who can join

Adults 40 to 65, any sex, with Immune Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The COVID-19 pandemic highlights the importance of good nutritional status for immune strength and for reducing comorbidities that increase morbidity and mortality of infections. The major aim of this study is test if almond consumption can improve immune function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Almond

Trials testing the same drug.

Other San Diego State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05059639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing